The framework has shifted from distribution to markup since the last review. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 63% above its long-term trend line with momentum reading overbought. Over the past year the shares are up 115%. Our forward projection puts the odds of a 10% gain over the next month near 31%. The street (11 analysts) rates it buy, with a mean price target of $270. It reported earnings in this window, a natural checkpoint for the thesis.
TD Synnex Corp
SNX · the NYSE · USD · 24,000 employees
TD SYNNEX Corporation operates as a distributor and solutions aggregator for the information technology (IT) ecosystem in the United States, Europe, and internationally.
PASS · Titan Ethical · score 70.0At the last full screen
2026-09-02
Screened 2026-09-02 · the tape above runs as of 17:00 UTC · two dates, stated on purpose · verdict and workings shown in full · never trimmed
This name holds its markup label.
TD Synnex Corp holds its Markup at $253.06. The statistical read favours the sellers, held for 44 days.
| Phase | Markup |
| Quantitative state | The statistical read favours the sellers, held for 44 days |
| Price at the screen | $253.06 |
| Valuation | 18.14 trailing · 11.82 forward price to earnings |
| Values screen | PASS · score 70.0 |
| Beta | 1.44 |
Five Screens, Shown in Full
Full pass across all five screens. This security clears the Titan Ethical Standard: its business and its balance sheet both stay inside the lines.
| Test | Figure | Limit | What it means | Status |
|---|---|---|---|---|
| Business activity | Permissible | Core business clean | Its core business isn't built on prohibited lines: no gambling, alcohol, tobacco, weapons, or interest-based lending. | Pass |
| Debt load | 13.46% | Below 33% | Interest-bearing debt is just 13.5% of its assets, well under the one-third ceiling: it does not run on borrowed money. | Pass |
| Interest-bearing cash | 0.00% | Below 33% | Cash held in interest-bearing accounts and securities is 0.0% of assets, under the one-third limit. | Pass |
| Receivables | 41.29% | Below 49% | Money owed to the company is 41.3% of assets, under the 49% limit. | Pass |
| Revenue purity | 0.00% | Below 5% | Only 0.0% of revenue comes from non-compliant sources, under the 5% line. | Pass |
Five checks adapted from AAOIFI screening standards: business activity plus four balance-sheet ratios. All five must pass for ethical clearance. Every figure is arithmetic on public accounts, not judgement.
What the Numbers Say It Is WorthThe Fair Value Range
Fair value range in USD, drawn from the 2026-09-02 screen. The gold marker is the market price at the same screen. A 47.8% margin of safety to the base estimate.
Third-party analyst targets: 11 covering, consensus Buy. The average target sits +30% from the screen price.
Reading the gap · Both our model and the analysts see meaningful upside from here.
Price History & ProjectionsWhere it has been, where the models see it going. History from market close data; projection points are our fair-value estimates and third-party analyst targets, dated to the 2026-09-02 screen.
Fair value and rating are our own model estimates; the Street's range reflects third-party analyst estimates. Analysis, not advice.
The Business, in Plain WordsWarehouse scale but thin margins
Picture a vast warehouse shifting laptops, servers and phones from factories to offices across three continents. TD Synnex sits in the middle of that flow, posting 31 percent revenue growth while trading at 11.3 times forward earnings and a 54 percent gap to our fair value. The numbers look attractive on paper.
We still pass. Profit margins sit at just 2 percent, return on equity reaches only 13 percent, and the moat is narrow in a business where customers can switch distributors with little friction. Ethical screens clear, yet the operating model leaves scant room for error once growth normalises.
Distribution volumes move with hardware cycles and inventory swings. A sudden tech slowdown can turn modest margins into losses fast, which is why the low multiple does not signal a bargain here. Analysis, not advice.
| Forward P/E | 11.8xcheap for a company growing this fast |
| Trailing P/E | 18.1xreasonably valued |
| EPS, trailing | 13.95 |
| EPS, forward | 21.41 |
| Revenue growth | +31.0%strong top-line growth |
| Profit margin | 1.6%barely profitable |
| Return on equity | 13.1%a solid return on shareholder capital |
| Dividend yield | 68.00% |
| Debt to equity | 0.53moderate, manageable leverage |
| Current ratio | 1.20adequate liquidity, worth monitoring |
| Beta | 1.44moves a little more than the market |
| Short interest, float | 0.03% |
| 52-week range | 142.22 - 296.47 |
| Moat | NARROW |
| Employees | 24,000 |
The risks · The things to watch: it already moves more than the market on an average day.
Plain-English interpretation of our own screen data. Analysis, not advice.
Where & How to TradeSNX trades on the NYSE. As a listed security it is accessible through almost any international broker offering its home market. New to this, or investing from abroad? Our guide to accessing global markets covers brokers, currencies and the practical steps.
Every Entry, As Written
The framework has shifted from markup to distribution since the last review. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 63% above its long-term trend line with momentum reading overbought. Over the past year the shares are up 115%. Our forward projection puts the odds of a 10% gain over the next month near 31%. The street (11 analysts) rates it buy, with a mean price target of $270. It reported earnings in this window, a natural checkpoint for the thesis.
The framework has shifted from distribution to markup since the last review. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved up 2.4% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 63% above its long-term trend line with momentum reading overbought. Over the past year the shares are up 115%. Our forward projection puts the odds of a 10% gain over the next month near 31%. The street (11 analysts) rates it buy, with a mean price target of $270.
The framework has shifted from markup to distribution since the last review. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 11.9% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 63% above its long-term trend line with momentum reading overbought. Over the past year the shares are up 115%. Our forward projection puts the odds of a 10% gain over the next month near 31%. The street (11 analysts) rates it buy, with a mean price target of $270.
The framework reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 63% above its long-term trend line with momentum reading overbought. Over the past year the shares are up 115%. Our forward projection puts the odds of a 10% gain over the next month near 31%. The street (11 analysts) rates it buy, with a mean price target of $270.
The framework reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen (70). The risk-adjusted return profile shows excellent risk-adjusted returns.
The framework reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Ethical screening: PASS with passing ethical screen (70). The risk-adjusted return profile shows excellent risk-adjusted returns.
Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.
- Should Fortinet’s New TD SYNNEX Partnership and AI Endpoint Upgrades Require Action From Fortinet (FTNT) Investors? Simply Wall St. · 18 Jul 2026
- 3 Growth Stocks to Add to Your Roster StockStory · 15 Jul 2026
- What Investors Keep Asking About SNX Trefis · 10 Jul 2026
- TD SYNNEX (SNX) Stock May Be 15% Cheap Despite $1b Buyback Simply Wall St. · 10 Jul 2026
- Is TD SYNNEX (SNX) Quietly Rewriting Its Capital Allocation Playbook With Buybacks and Dividends? Simply Wall St. · 9 Jul 2026
Headlines from third-party outlets, linked for reference: not our reporting, not advice.
Screened names in the same industry · explore each on its own page.
| Period | Price then | Price return | Divs per share | $1,000 became | Total return |
|---|---|---|---|---|---|
| 1 month | $237.02 | +13.0% | · | $1,130 | +13.0% |
| 2 months | $199.22 | +34.4% | $0.48 | $1,346 | +34.6% |
| 3 months | $153.05 | +74.9% | $0.48 | $1,752 | +75.2% |
| 6 months | $156.47 | +71.1% | $0.96 | $1,717 | +71.7% |
| 1 year | $124.78 | +114.6% | $1.84 | $2,160 | +116.0% |
| 2 years | $127.29 | +110.3% | $3.52 | $2,131 | +113.1% |
| 3 years | $89.31 | +199.8% | $5.02 | $3,054 | +205.4% |
| 5 years | $121.46 | +120.4% | $7.32 | $2,264 | +126.4% |
Historical returns from market close data. Past performance does not guarantee future results.
This entry now belongs to the ledger. Whatever SNX does next, these words stay.
Thirteen thousand names carry this page. One desk keeps them honest.
Membership opens the full screen archive, the composites built from it, and the daily coverage that prices what the screen approves.
Join the deskScreening is research, not a fatwa and not financial advice. Figures are drawn from public accounts at the screen date shown. Always manage your risk.